SH3D21 rs34416442 genetic variation is associated with pancreatic cancer patients' overall survival and their response to gemcitabine
{{output}}
Pancreatic cancer remains one of the most lethal malignancies worldwide due to late diagnosis and limited therapeutic response. Gemcitabine is widely used as a first-line chemotherapeutic agent, and SH3D21 has been identified as a gemcitabine sensitizer in pan... ...
